FZD7 and metabolic dysfunction-associated steatotic liver disease: A significant increase in FZD7 expression was observed when the cells were treated with exosomes derived from patients with NAFLD compared to the cells treated with exosomes derived from healthy subjects and to control cells (ANOVA and Tukey’s post-test, * p < 0.05, ** p < 0.001).